Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 1-1 is a gene segment within the immunoglobulin heavy chain locus (IGH) containing the coding sequence for the variable region of the immunoglobulin heavy chain. These gene segments undergo somatic V(D)J recombination in developing B lymphocytes, generating the diverse antigen-binding sites of antibodies. It is not a classical receptor, enzyme, or drug target. Individual IGHV segments, such as IGHV1-1, contribute to antibody diversity and specificity but are not druggable themselves. Abnormal usage of certain IGHV genes may be associated with lymphoid malignancies or autoimmune diseases, although IGHV1-1 is not among the most commonly reported stereotyped IGHV segments. The submitted names "IGHVII-1-1" or "IGHV(II)-1-1" do not conform to major accepted nomenclature and likely arise from a misspelling or a non-standard nomenclature source.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 1-1 (IGHV1-1).